메뉴 건너뛰기




Volumn 85, Issue 21, 2011, Pages 11502-11519

Polyclonal B cell responses to conserved neutralization epitopes in a subset of HIV-1-infected individuals

(24)  Tomaras, Georgia D a   Binley, James M b   Gray, Elin S c   Crooks, Emma T b   Osawa, Keiko b   Moore, Penny L c   Tumba, Nancy c   Tong, Tommy b   Shen, Xiaoying b   Yates, Nicole L a   Decker, Julie b   Wibmer, Constantinos Kurt c   Gao, Feng a   Alam, S Munir a   Easterbrook, Philippa d   Karim, Salim Abdool e   Kamanga, Gift f   Crump, John A a,g   Cohen, Myron h   Shaw, George M i   more..


Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CENTROMERE ANTIBODY; DOUBLE STRANDED DNA ANTIBODY; EPITOPE; GLYCAN; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41; HISTONE ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; JO 1 ANTIBODY; LA ANTIBODY; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; RIBONUCLEOPROTEIN ANTIBODY; RO ANTIBODY; SM ANTIBODY; VIRUS ENVELOPE PROTEIN;

EID: 80055104586     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.05363-11     Document Type: Article
Times cited : (163)

References (111)
  • 1
    • 0037847545 scopus 로고    scopus 로고
    • Human immunodeficiency virus type 1 Env with an intersubunit disulfide bond engages coreceptors but requires bond reduction after engagement to induce fusion
    • Abrahamyan, L. G., R. M. Markosyan, J. P. Moore, F. S. Cohen, and G. B. Melikyan. 2003. Human immunodeficiency virus type 1 Env with an intersubunit disulfide bond engages coreceptors but requires bond reduction after engagement to induce fusion. J. Virol. 77:5829-5836.
    • (2003) J. Virol. , vol.77 , pp. 5829-5836
    • Abrahamyan, L.G.1    Markosyan, R.M.2    Moore, J.P.3    Cohen, F.S.4    Melikyan, G.B.5
  • 2
    • 0027223565 scopus 로고
    • Molecular profile of an antibody response to HIV-1 as probed by combinatorial libraries
    • Barbas, C. F., III, et al. 1993. Molecular profile of an antibody response to HIV-1 as probed by combinatorial libraries. J. Mol. Biol. 230:812-823.
    • (1993) J. Mol. Biol. , vol.230 , pp. 812-823
    • Barbas III, C.F.1
  • 4
    • 69549086342 scopus 로고    scopus 로고
    • Specificities of broadly neutralizing anti-HIV-1 sera
    • Binley, J. M. 2009. Specificities of broadly neutralizing anti-HIV-1 sera. Curr. Opin. HIV AIDS 4:364-372.
    • (2009) Curr. Opin. HIV AIDS , vol.4 , pp. 364-372
    • Binley, J.M.1
  • 5
    • 0038076112 scopus 로고    scopus 로고
    • Redox-triggered infection by disulfide-shackled human immunodeficiency virus type 1 pseudovirions
    • Binley, J. M., et al. 2003. Redox-triggered infection by disulfide-shackled human immunodeficiency virus type 1 pseudovirions. J. Virol. 77:5678-5684.
    • (2003) J. Virol. , vol.77 , pp. 5678-5684
    • Binley, J.M.1
  • 6
    • 0030897105 scopus 로고    scopus 로고
    • Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1
    • Binley, J. M., et al. 1997. Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1. J. Virol. 71:2799-2809.
    • (1997) J. Virol. , vol.71 , pp. 2799-2809
    • Binley, J.M.1
  • 7
    • 56449131391 scopus 로고    scopus 로고
    • Profiling the specificity of neutralizing antibodies in a large panel of HIV-1 plasma samples from subtype B and C chronic infections
    • Binley, J. M., et al. 2008. Profiling the specificity of neutralizing antibodies in a large panel of HIV-1 plasma samples from subtype B and C chronic infections. J. Virol. 82:11651-11668.
    • (2008) J. Virol. , vol.82 , pp. 11651-11668
    • Binley, J.M.1
  • 8
    • 8644251891 scopus 로고    scopus 로고
    • Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies
    • Binley, J. M., et al. 2004. Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies. J. Virol. 78:13232-13252.
    • (2004) J. Virol. , vol.78 , pp. 13232-13252
    • Binley, J.M.1
  • 9
    • 38849205377 scopus 로고    scopus 로고
    • Enhancing exposure of HIV-1 neutralization epitopes through mutations in gp41
    • Blish, C. A., M. A. Nguyen, and J. Overbaugh. 2008. Enhancing exposure of HIV-1 neutralization epitopes through mutations in gp41. PLoS Med. 5:e9.
    • (2008) PLoS Med , vol.5
    • Blish, C.A.1    Nguyen, M.A.2    Overbaugh, J.3
  • 10
    • 80052938385 scopus 로고    scopus 로고
    • Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors
    • Bonsignori, M., et al. 2011. Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors. J. Virol. 85:9998-10009.
    • (2011) J. Virol. , vol.85 , pp. 9998-10009
    • Bonsignori, M.1
  • 11
    • 49149118421 scopus 로고    scopus 로고
    • Autologous neutralizing humoral immunity and evolution of the viral envelope in the course of subtype B human immunodeficiency virus type 1 infection
    • Bunnik, E. M., L. Pisas, A. C. van Nuenen, and H. Schuitemaker. 2008. Autologous neutralizing humoral immunity and evolution of the viral envelope in the course of subtype B human immunodeficiency virus type 1 infection. J. Virol. 82:7932-7941.
    • (2008) J. Virol. , vol.82 , pp. 7932-7941
    • Bunnik, E.M.1    Pisas, L.2    van Nuenen, A.C.3    Schuitemaker, H.4
  • 12
    • 1542317452 scopus 로고    scopus 로고
    • HIV vaccine design and the neutralizing antibody problem
    • Burton, D. R., et al. 2004. HIV vaccine design and the neutralizing antibody problem. Nat. Immunol. 5:233-236.
    • (2004) Nat. Immunol. , vol.5 , pp. 233-236
    • Burton, D.R.1
  • 13
    • 0027985431 scopus 로고
    • Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody
    • Burton, D. R., et al. 1994. Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. Science 266:1024-1027.
    • (1994) Science , vol.266 , pp. 1024-1027
    • Burton, D.R.1
  • 14
    • 12444291017 scopus 로고    scopus 로고
    • Antibody domain exchange is an immunological solution to carbohydrate cluster recognition
    • Calarese, D. A., et al. 2003. Antibody domain exchange is an immunological solution to carbohydrate cluster recognition. Science 300:2065-2071.
    • (2003) Science , vol.300 , pp. 2065-2071
    • Calarese, D.A.1
  • 15
    • 0031025113 scopus 로고    scopus 로고
    • Macrophage tropism of human immunodeficiency virus type 1 and utilization of the CC-CKR5 coreceptor
    • Cheng-Mayer, C., R. Liu, N. R. Landau, and L. Stamatatos. 1997. Macrophage tropism of human immunodeficiency virus type 1 and utilization of the CC-CKR5 coreceptor. J. Virol. 71:1657-1661.
    • (1997) J. Virol. , vol.71 , pp. 1657-1661
    • Cheng-Mayer, C.1    Liu, R.2    Landau, N.R.3    Stamatatos, L.4
  • 16
    • 34247559067 scopus 로고    scopus 로고
    • Cross-reactive HIV-1 neutralizing monoclonal antibodies selected by screening of an immune human phage library against an envelope glycoprotein (gp140) isolated from a patient (R2) with broadly HIV-1 neutralizing antibodies
    • Choudhry, V., et al. 2007. Cross-reactive HIV-1 neutralizing monoclonal antibodies selected by screening of an immune human phage library against an envelope glycoprotein (gp140) isolated from a patient (R2) with broadly HIV-1 neutralizing antibodies. Virology 363:79-90.
    • (2007) Virology , vol.363 , pp. 79-90
    • Choudhry, V.1
  • 18
    • 77649318846 scopus 로고    scopus 로고
    • Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individuals
    • Corti, D., et al. 2010. Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individuals. PLoS One 5:e8805.
    • (2010) PLoS One , vol.5
    • Corti, D.1
  • 19
    • 45049083040 scopus 로고    scopus 로고
    • Relationship of HIV-1 and SIV envelope glycoprotein trimer occupation and neutralization
    • Crooks, E. T., et al. 2008. Relationship of HIV-1 and SIV envelope glycoprotein trimer occupation and neutralization. Virology 377:364-378.
    • (2008) Virology , vol.377 , pp. 364-378
    • Crooks, E.T.1
  • 20
    • 34548577658 scopus 로고    scopus 로고
    • A comparative immunogenicity study of HIV-1 virus-like particles bearing various forms of envelope proteins, particles bearing no envelope and soluble monomeric gp120
    • Crooks, E. T., et al. 2007. A comparative immunogenicity study of HIV-1 virus-like particles bearing various forms of envelope proteins, particles bearing no envelope and soluble monomeric gp120. Virology 366:245-262.
    • (2007) Virology , vol.366 , pp. 245-262
    • Crooks, E.T.1
  • 21
    • 33646720281 scopus 로고    scopus 로고
    • Characterizing anti-HIV monoclonal antibodies and immune sera by defining the mechanism of neutralization
    • Crooks, E. T., et al. 2005. Characterizing anti-HIV monoclonal antibodies and immune sera by defining the mechanism of neutralization. Hum. Antibodies 14:101-113.
    • (2005) Hum. Antibodies , vol.14 , pp. 101-113
    • Crooks, E.T.1
  • 22
    • 0026675432 scopus 로고
    • Spectrotype of anti-gp120 antibodies remains stable during the course of HIV disease
    • D'Amelio, R., et al. 1992. Spectrotype of anti-gp120 antibodies remains stable during the course of HIV disease. J. Acquir. Immune Defic. Syndr. 5:930-935.
    • (1992) J. Acquir. Immune Defic. Syndr. , vol.5 , pp. 930-935
    • D'Amelio, R.1
  • 23
    • 59749089778 scopus 로고    scopus 로고
    • Human immunodeficiency virus type 2 (HIV-2)/ HIV-1 envelope chimeras detect high titers of broadly reactive HIV-1 V3-specific antibodies in human plasma
    • Davis, K. L., et al. 2009. Human immunodeficiency virus type 2 (HIV-2)/ HIV-1 envelope chimeras detect high titers of broadly reactive HIV-1 V3-specific antibodies in human plasma. J. Virol. 83:1240-1259.
    • (2009) J. Virol. , vol.83 , pp. 1240-1259
    • Davis, K.L.1
  • 24
    • 20844448731 scopus 로고    scopus 로고
    • Antigenic conservation and immunogenicity of the HIV coreceptor binding site
    • Decker, J. M., et al. 2005. Antigenic conservation and immunogenicity of the HIV coreceptor binding site. J. Exp. Med. 201:1407-1419.
    • (2005) J. Exp. Med. , vol.201 , pp. 1407-1419
    • Decker, J.M.1
  • 25
    • 34249950588 scopus 로고    scopus 로고
    • Dissecting the neutralizing antibody specificities of broadly neutralizing sera from human immunodeficiency virus type 1-infected donors
    • Dhillon, A. K., et al. 2007. Dissecting the neutralizing antibody specificities of broadly neutralizing sera from human immunodeficiency virus type 1-infected donors. J. Virol. 81:6548-6562.
    • (2007) J. Virol. , vol.81 , pp. 6548-6562
    • Dhillon, A.K.1
  • 26
    • 77957198704 scopus 로고    scopus 로고
    • Variable loop glycan dependency of the broad and potent HIV-1-neutralizing antibodies PG9 and PG16
    • Doores, K. J., and D. R. Burton. 2010. Variable loop glycan dependency of the broad and potent HIV-1-neutralizing antibodies PG9 and PG16. J. Virol. 84:10510-10521.
    • (2010) J. Virol. , vol.84 , pp. 10510-10521
    • Doores, K.J.1    Burton, D.R.2
  • 27
    • 73949084963 scopus 로고    scopus 로고
    • Breadth of human immunodeficiency virusspecific neutralizing activity in sera: clustering analysis and association with clinical variables
    • Doria-Rose, N. A., et al. 2010. Breadth of human immunodeficiency virusspecific neutralizing activity in sera: clustering analysis and association with clinical variables. J. Virol. 84:1631-1636.
    • (2010) J. Virol. , vol.84 , pp. 1631-1636
    • Doria-Rose, N.A.1
  • 28
    • 84887212581 scopus 로고    scopus 로고
    • International network for comparison of HIV neutralization assays: the NeutNet report
    • Fenyo, E. M., et al. 2009. International network for comparison of HIV neutralization assays: the NeutNet report. PLoS One 4:e4505.
    • (2009) PLoS One , vol.4
    • Fenyo, E.M.1
  • 29
    • 57349165849 scopus 로고    scopus 로고
    • Llama antibody fragments with cross-subtype human immunodeficiency virus type 1 (HIV-1)-neutralizing properties and high affinity for HIV-1 gp120
    • Forsman, A., et al. 2008. Llama antibody fragments with cross-subtype human immunodeficiency virus type 1 (HIV-1)-neutralizing properties and high affinity for HIV-1 gp120. J. Virol. 82:12069-12081.
    • (2008) J. Virol. , vol.82 , pp. 12069-12081
    • Forsman, A.1
  • 30
    • 0030897825 scopus 로고    scopus 로고
    • Neutralization of the human immunodeficiency virus type 1 primary isolate JR-FL by human monoclonal antibodies correlates with antibody binding to the oligomeric form of the envelope glycoprotein complex
    • Fouts, T. R., J. M. Binley, A. Trkola, J. E. Robinson, and J. P. Moore. 1997. Neutralization of the human immunodeficiency virus type 1 primary isolate JR-FL by human monoclonal antibodies correlates with antibody binding to the oligomeric form of the envelope glycoprotein complex. J. Virol. 71: 2779-2785.
    • (1997) J. Virol. , vol.71 , pp. 2779-2785
    • Fouts, T.R.1    Binley, J.M.2    Trkola, A.3    Robinson, J.E.4    Moore, J.P.5
  • 31
    • 0030018993 scopus 로고    scopus 로고
    • Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G The WHO and NIAID Networks for HIV Isolation and Characterization
    • Gao, F., et al. 1996. Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization. J. Virol. 70:1651-1667.
    • (1996) J. Virol. , vol.70 , pp. 1651-1667
    • Gao, F.1
  • 32
    • 78349299783 scopus 로고    scopus 로고
    • Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies
    • Gnanakaran, S., et al. 2010. Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies. PLoS Comput. Biol. 6:e1000955.
    • (2010) PLoS Comput. Biol. , vol.6
    • Gnanakaran, S.1
  • 33
    • 16244419386 scopus 로고    scopus 로고
    • Identification of a new quaternary neutralizing epitope on human immunodeficiency virus type 1 virus particles
    • Gorny, M. K., et al. 2005. Identification of a new quaternary neutralizing epitope on human immunodeficiency virus type 1 virus particles. J. Virol. 79:5232-5237.
    • (2005) J. Virol. , vol.79 , pp. 5232-5237
    • Gorny, M.K.1
  • 34
    • 79955389756 scopus 로고    scopus 로고
    • The neutralization breadth of HIV-1 develops incrementally over four years and is associated with CD4' T cell decline and high viral load during acute infection
    • Gray, E. S., et al. 2011. The neutralization breadth of HIV-1 develops incrementally over four years and is associated with CD4' T cell decline and high viral load during acute infection. J. Virol. 85:4828-4840.
    • (2011) J. Virol. , vol.85 , pp. 4828-4840
    • Gray, E.S.1
  • 35
    • 70350320582 scopus 로고    scopus 로고
    • Broad neutralization of human immunodeficiency virus type 1 mediated by plasma antibodies against the gp41 membrane proximal external region
    • Gray, E. S., et al. 2009. Broad neutralization of human immunodeficiency virus type 1 mediated by plasma antibodies against the gp41 membrane proximal external region. J. Virol. 83:11265-11274.
    • (2009) J. Virol. , vol.83 , pp. 11265-11274
    • Gray, E.S.1
  • 36
    • 79960413187 scopus 로고    scopus 로고
    • Isolation of a monoclonal antibody that targets the alpha-2 helix of gp120 and represents the initial autologous neutralizingantibody response in an HIV-1 subtype C-infected individual
    • Gray, E. S., et al. 2011. Isolation of a monoclonal antibody that targets the alpha-2 helix of gp120 and represents the initial autologous neutralizingantibody response in an HIV-1 subtype C-infected individual. J. Virol. 85:7719-7729.
    • (2011) J. Virol. , vol.85 , pp. 7719-7729
    • Gray, E.S.1
  • 37
    • 39749136530 scopus 로고    scopus 로고
    • 4E10-resistant variants in a human immunodeficiency virus type 1 subtype C-infected individual with an anti-membraneproximal external region-neutralizing antibody response
    • Gray, E. S., et al. 2008. 4E10-resistant variants in a human immunodeficiency virus type 1 subtype C-infected individual with an anti-membraneproximal external region-neutralizing antibody response. J. Virol. 82:2367-2375.
    • (2008) J. Virol. , vol.82 , pp. 2367-2375
    • Gray, E.S.1
  • 38
    • 34249940652 scopus 로고    scopus 로고
    • Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infection
    • Gray, E. S., et al. 2007. Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infection. J. Virol. 81:6187-6196.
    • (2007) J. Virol. , vol.81 , pp. 6187-6196
    • Gray, E.S.1
  • 39
    • 69249208675 scopus 로고    scopus 로고
    • Antibody specificities associated with neutralization breadth in plasma from human immunodeficiency virus type 1 subtype C-infected blood donors
    • Gray, E. S., et al. 2009. Antibody specificities associated with neutralization breadth in plasma from human immunodeficiency virus type 1 subtype C-infected blood donors. J. Virol. 83:8925-8937.
    • (2009) J. Virol. , vol.83 , pp. 8925-8937
    • Gray, E.S.1
  • 40
    • 79551556431 scopus 로고    scopus 로고
    • Heterologous epitope-scaffold prime:boosting immuno-focuses B cell responses to the HIV-1 gp41 2F5 neutralization determinant
    • Guenaga, J., et al. 2011. Heterologous epitope-scaffold prime:boosting immuno-focuses B cell responses to the HIV-1 gp41 2F5 neutralization determinant. PLoS One 6:e16074.
    • (2011) PLoS One , vol.6
    • Guenaga, J.1
  • 41
    • 0028670687 scopus 로고
    • Analysis of B cell repertoire specific to the neutralizing epitopes of glycoprotein 120 in HIV-infected individuals
    • Hariharan, K., P. L. Nara, L. A. Shabazz, J. A. McCutchan, and C. Y. Kang. 1994. Analysis of B cell repertoire specific to the neutralizing epitopes of glycoprotein 120 in HIV-infected individuals. AIDS Res. Hum. Retroviruses 10:1629-1637.
    • (1994) AIDS Res. Hum. Retroviruses , vol.10 , pp. 1629-1637
    • Hariharan, K.1    Nara, P.L.2    Shabazz, L.A.3    McCutchan, J.A.4    Kang, C.Y.5
  • 42
  • 43
    • 21344434534 scopus 로고    scopus 로고
    • Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies
    • Haynes, B. F., et al. 2005. Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies. Science 308:1906-1908.
    • (2005) Science , vol.308 , pp. 1906-1908
    • Haynes, B.F.1
  • 44
    • 68349160853 scopus 로고    scopus 로고
    • Effective, low titer, antibody protection against low dose repeated mucosal SHIV challenge in macaques
    • Hessell, A. J., et al. 2009. Effective, low titer, antibody protection against low dose repeated mucosal SHIV challenge in macaques. Nat. Med. 15: 951-954.
    • (2009) Nat. Med. , vol.15 , pp. 951-954
    • Hessell, A.J.1
  • 45
    • 67249131966 scopus 로고    scopus 로고
    • Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titers
    • Hessell, A. J., et al. 2009. Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titers. PLoS Pathog. 5:e1000433.
    • (2009) PLoS Pathog , vol.5
    • Hessell, A.J.1
  • 47
    • 77954110431 scopus 로고    scopus 로고
    • Anti-V3 monoclonal antibodies display broad neutralizing activities against multiple HIV-1 subtypes
    • Hioe, C. E., et al. 2010. Anti-V3 monoclonal antibodies display broad neutralizing activities against multiple HIV-1 subtypes. PLoS One 5:e10254.
    • (2010) PLoS One , vol.5
    • Hioe, C.E.1
  • 48
    • 34249952292 scopus 로고    scopus 로고
    • Macaques infected with a CCR5-tropic simian/human immunodeficiency virus (SHIV) develop broadly reactive anti-HIV neutralizing antibodies
    • Kraft, Z., et al. 2007. Macaques infected with a CCR5-tropic simian/human immunodeficiency virus (SHIV) develop broadly reactive anti-HIV neutralizing antibodies. J. Virol. 81:6402-6411.
    • (2007) J. Virol. , vol.81 , pp. 6402-6411
    • Kraft, Z.1
  • 49
    • 0141521564 scopus 로고    scopus 로고
    • Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1
    • Labrijn, A. F., et al. 2003. Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1. J. Virol. 77:10557-10565.
    • (2003) J. Virol. , vol.77 , pp. 10557-10565
    • Labrijn, A.F.1
  • 50
    • 23244434512 scopus 로고    scopus 로고
    • Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies
    • Li, M., et al. 2005. Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies. J. Virol. 79:10108-10125.
    • (2005) J. Virol. , vol.79 , pp. 10108-10125
    • Li, M.1
  • 51
    • 33751224478 scopus 로고    scopus 로고
    • Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa
    • Li, M., et al. 2006. Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa. J. Virol. 80: 11776-11790.
    • (2006) J. Virol. , vol.80 , pp. 11776-11790
    • Li, M.1
  • 52
    • 34948854718 scopus 로고    scopus 로고
    • Broad HIV-1 neutralization mediated by CD4 binding site antibodies
    • Li, Y., et al. 2007. Broad HIV-1 neutralization mediated by CD4 binding site antibodies. Nat. Med. 13:1032-1034.
    • (2007) Nat. Med. , vol.13 , pp. 1032-1034
    • Li, Y.1
  • 53
    • 58149517700 scopus 로고    scopus 로고
    • Analysis of neutralization specificities in polyclonal sera derived from human immunodeficiency virus type 1-infected individuals
    • Li, Y., et al. 2009. Analysis of neutralization specificities in polyclonal sera derived from human immunodeficiency virus type 1-infected individuals. J. Virol. 83:1045-1059.
    • (2009) J. Virol. , vol.83 , pp. 1045-1059
    • Li, Y.1
  • 54
    • 64949164763 scopus 로고    scopus 로고
    • High-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodies
    • Liao, H. X., et al. 2009. High-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodies. J. Virol. Methods 158:171-179.
    • (2009) J. Virol. Methods , vol.158 , pp. 171-179
    • Liao, H.X.1
  • 55
    • 0037029924 scopus 로고    scopus 로고
    • Passive transfer studies to elucidate the role of antibody-mediated protection against HIV-1
    • Mascola, J. R. 2002. Passive transfer studies to elucidate the role of antibody-mediated protection against HIV-1. Vaccine 20:1922-1925.
    • (2002) Vaccine , vol.20 , pp. 1922-1925
    • Mascola, J.R.1
  • 56
    • 0037393393 scopus 로고    scopus 로고
    • HIV-1 nature's master of disguise
    • Mascola, J. R., and D. C. Montefiori. 2003. HIV-1: nature's master of disguise. Nat. Med. 9:393-394.
    • (2003) Nat. Med. , vol.9 , pp. 393-394
    • Mascola, J.R.1    Montefiori, D.C.2
  • 57
    • 77952311370 scopus 로고    scopus 로고
    • The role of antibodies in HIV vaccines
    • Mascola, J. R., and D. C. Montefiori. 2010. The role of antibodies in HIV vaccines. Annu. Rev. Immunol. 28:413-444.
    • (2010) Annu. Rev. Immunol. , vol.28 , pp. 413-444
    • Mascola, J.R.1    Montefiori, D.C.2
  • 58
    • 0033951746 scopus 로고    scopus 로고
    • Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies
    • Mascola, J. R., et al. 2000. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat. Med. 6:207-210.
    • (2000) Nat. Med. , vol.6 , pp. 207-210
    • Mascola, J.R.1
  • 60
    • 79551518897 scopus 로고    scopus 로고
    • Characteristics of the earliest cross-neutralizing antibody response to HIV-1
    • Mikell, I., et al. 2011. Characteristics of the earliest cross-neutralizing antibody response to HIV-1. PLoS Pathog. 7:e1001251.
    • (2011) PLoS Pathog , vol.7
    • Mikell, I.1
  • 61
    • 40849136223 scopus 로고    scopus 로고
    • The membrane-proximal external region of the human immunodeficiency virus type 1 envelope: dominant site of antibody neutralization and target for vaccine design
    • Montero, M., N. E. van Houten, X. Wang, and J. K. Scott. 2008. The membrane-proximal external region of the human immunodeficiency virus type 1 envelope: dominant site of antibody neutralization and target for vaccine design. Microbiol. Mol. Biol. Rev. 72:54-84.
    • (2008) Microbiol. Mol. Biol. Rev. , vol.72 , pp. 54-84
    • Montero, M.1    van Houten, N.E.2    Wang, X.3    Scott, J.K.4
  • 62
    • 33144486096 scopus 로고    scopus 로고
    • Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1
    • Moore, P. L., et al. 2006. Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1. J. Virol. 80:2515-2528.
    • (2006) J. Virol. , vol.80 , pp. 2515-2528
    • Moore, P.L.1
  • 63
    • 38849090714 scopus 로고    scopus 로고
    • The C3-V4 region is a major target of autologous neutralizing antibodies in human immunodeficiency virus type 1 subtype C infection
    • Moore, P. L., et al. 2008. The C3-V4 region is a major target of autologous neutralizing antibodies in human immunodeficiency virus type 1 subtype C infection. J. Virol. 82:1860-1869.
    • (2008) J. Virol. , vol.82 , pp. 1860-1869
    • Moore, P.L.1
  • 64
    • 79952579682 scopus 로고    scopus 로고
    • Potent and broad neutralization of HIV-1 subtype C viruses by plasma antibodies targeting a quaternary epitope including residues in the V2 loop
    • Moore, P. L., et al. 2011. Potent and broad neutralization of HIV-1 subtype C viruses by plasma antibodies targeting a quaternary epitope including residues in the V2 loop. J. Virol. 85:3128-3141.
    • (2011) J. Virol. , vol.85 , pp. 3128-3141
    • Moore, P.L.1
  • 65
    • 70349686331 scopus 로고    scopus 로고
    • Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection
    • Moore, P. L., et al. 2009. Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection. PLoS Pathog. 5:e1000598.
    • (2009) PLoS Pathog , vol.5
    • Moore, P.L.1
  • 66
    • 79551700244 scopus 로고    scopus 로고
    • A conserved determinant in the V1 loop of HIV-1 modulates the V3 loop to prime low CD4 use and macrophage infection
    • Musich, T., et al. 2011. A conserved determinant in the V1 loop of HIV-1 modulates the V3 loop to prime low CD4 use and macrophage infection. J. Virol. 85:2397-2405.
    • (2011) J. Virol. , vol.85 , pp. 2397-2405
    • Musich, T.1
  • 67
    • 0027378573 scopus 로고
    • A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1
    • Muster, T., et al. 1993. A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1. J. Virol. 67:6642-6647.
    • (1993) J. Virol. , vol.67 , pp. 6642-6647
    • Muster, T.1
  • 68
    • 71049141219 scopus 로고    scopus 로고
    • Epitopes for broad and potent neutralizing antibody responses during chronic infection with human immunodeficiency virus type 1
    • Nandi, A., et al. 2010. Epitopes for broad and potent neutralizing antibody responses during chronic infection with human immunodeficiency virus type 1. Virology 396:339-348.
    • (2010) Virology , vol.396 , pp. 339-348
    • Nandi, A.1
  • 69
    • 34247106331 scopus 로고    scopus 로고
    • An affinity-enhanced neutralizing antibody against the membrane-proximal external region of human immunodeficiency virus type 1 gp41 recognizes an epitope between those of 2F5 and 4E10
    • Nelson, J. D., et al. 2007. An affinity-enhanced neutralizing antibody against the membrane-proximal external region of human immunodeficiency virus type 1 gp41 recognizes an epitope between those of 2F5 and 4E10. J. Virol. 81:4033-4043.
    • (2007) J. Virol. , vol.81 , pp. 4033-4043
    • Nelson, J.D.1
  • 70
    • 77957940271 scopus 로고    scopus 로고
    • Mutation at a single position in the V2 domain of the HIV-1 envelope protein confers neutralization sensitivity to a highly neutralization-resistant virus
    • O'Rourke, S. M., et al. 2010. Mutation at a single position in the V2 domain of the HIV-1 envelope protein confers neutralization sensitivity to a highly neutralization-resistant virus. J. Virol. 84:11200-11209.
    • (2010) J. Virol. , vol.84 , pp. 11200-11209
    • O'Rourke, S.M.1
  • 71
    • 0011993562 scopus 로고
    • A conserved region at the COOH terminus of human immunodeficiency virus gp120 envelope protein contains an immunodominant epitope
    • Palker, T. J., et al. 1987. A conserved region at the COOH terminus of human immunodeficiency virus gp120 envelope protein contains an immunodominant epitope. Proc. Natl. Acad. Sci. U. S. A. 84:2479-2483.
    • (1987) Proc. Natl. Acad. Sci. U. S. A. , vol.84 , pp. 2479-2483
    • Palker, T.J.1
  • 72
    • 34250027638 scopus 로고    scopus 로고
    • Analysis of the neutralization breadth of the anti-V3 antibody F425-B4e8 and re-assessment of its epitope fine specificity by scanning mutagenesis
    • Pantophlet, R., R. O. Aguilar-Sino, T. Wrin, L. A. Cavacini, and D. R. Burton. 2007. Analysis of the neutralization breadth of the anti-V3 antibody F425-B4e8 and re-assessment of its epitope fine specificity by scanning mutagenesis. Virology 364:441-453.
    • (2007) Virology , vol.364 , pp. 441-453
    • Pantophlet, R.1    Aguilar-Sino, R.O.2    Wrin, T.3    Cavacini, L.A.4    Burton, D.R.5
  • 73
    • 0034864776 scopus 로고    scopus 로고
    • Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro
    • Parren, P. W., et al. 2001. Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro. J. Virol. 75:8340-8347.
    • (2001) J. Virol. , vol.75 , pp. 8340-8347
    • Parren, P.W.1
  • 74
    • 33846172297 scopus 로고    scopus 로고
    • Rational modifications of HIV-1 envelope glycoproteins for immunogen design
    • Phogat, S., and R. Wyatt. 2007. Rational modifications of HIV-1 envelope glycoproteins for immunogen design. Curr. Pharm. Des. 13:213-227.
    • (2007) Curr. Pharm. Des. , vol.13 , pp. 213-227
    • Phogat, S.1    Wyatt, R.2
  • 77
    • 34249789875 scopus 로고    scopus 로고
    • Unique mutational patterns in the envelope α2 amphipathic helix and acquisition of length in gp120 hypervariable domains are associated with resistance to autologous neutralization of subtype C human immunodeficiency virus type 1
    • Rong, R., et al. 2007. Unique mutational patterns in the envelope α2 amphipathic helix and acquisition of length in gp120 hypervariable domains are associated with resistance to autologous neutralization of subtype C human immunodeficiency virus type 1. J. Virol. 81:5658-5668.
    • (2007) J. Virol. , vol.81 , pp. 5658-5668
    • Rong, R.1
  • 78
    • 70349695689 scopus 로고    scopus 로고
    • Escape from autologous neutralizing antibodies in acute/early subtype C HIV-1 infection requires multiple pathways
    • Rong, R., et al. 2009. Escape from autologous neutralizing antibodies in acute/early subtype C HIV-1 infection requires multiple pathways. PLoS Pathog. 5:e1000594.
    • (2009) PLoS Pathog , vol.5
    • Rong, R.1
  • 79
    • 0036637385 scopus 로고    scopus 로고
    • The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120
    • Sanders, R. W., et al. 2002. The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120. J. Virol. 76:7293-7305.
    • (2002) J. Virol. , vol.76 , pp. 7293-7305
    • Sanders, R.W.1
  • 80
    • 51149120614 scopus 로고    scopus 로고
    • Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection
    • Santiago, M. L., et al. 2008. Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection. Science 321:1343-1346.
    • (2008) Science , vol.321 , pp. 1343-1346
    • Santiago, M.L.1
  • 81
    • 58149487645 scopus 로고    scopus 로고
    • Factors associated with the development of cross-reactive neutralizing antibodies during human immunodeficiency virus type 1 infection
    • Sather, D. N., et al. 2009. Factors associated with the development of cross-reactive neutralizing antibodies during human immunodeficiency virus type 1 infection. J. Virol. 83:757-769.
    • (2009) J. Virol. , vol.83 , pp. 757-769
    • Sather, D.N.1
  • 82
    • 77952516203 scopus 로고    scopus 로고
    • Epitope specificities of broadly neutralizing plasmas from HIV-1 infected subjects
    • Sather, D. N., and L. Stamatatos. 2010. Epitope specificities of broadly neutralizing plasmas from HIV-1 infected subjects. Vaccine 28(Suppl. 2): B8-B12.
    • (2010) Vaccine , vol.28 , Issue.SUPPL. 2
    • Sather, D.N.1    Stamatatos, L.2
  • 83
    • 0028999803 scopus 로고
    • Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer
    • Sattentau, Q. J., and J. P. Moore. 1995. Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer. J. Exp. Med. 182:185-196.
    • (1995) J. Exp. Med. , vol.182 , pp. 185-196
    • Sattentau, Q.J.1    Moore, J.P.2
  • 84
    • 34247636624 scopus 로고    scopus 로고
    • Exploiting the defensive sugars of HIV-1 for drug and vaccine design
    • Scanlan, C. N., J. Offer, N. Zitzmann, and R. A. Dwek. 2007. Exploiting the defensive sugars of HIV-1 for drug and vaccine design. Nature 446:1038-1045.
    • (2007) Nature , vol.446 , pp. 1038-1045
    • Scanlan, C.N.1    Offer, J.2    Zitzmann, N.3    Dwek, R.A.4
  • 85
    • 18244422922 scopus 로고    scopus 로고
    • The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of →2 mannose residues on the outer face of gp120
    • Scanlan, C. N., et al. 2002. The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of →2 mannose residues on the outer face of gp120. J. Virol. 76:7306-7321.
    • (2002) J. Virol. , vol.76 , pp. 7306-7321
    • Scanlan, C.N.1
  • 86
    • 9144222999 scopus 로고    scopus 로고
    • The carbohydrate epitope of the neutralizing anti-HIV-1 antibody 2G12
    • Scanlan, C. N., et al. 2003. The carbohydrate epitope of the neutralizing anti-HIV-1 antibody 2G12. Adv. Exp. Med. Biol. 535:205-218.
    • (2003) Adv. Exp. Med. Biol. , vol.535 , pp. 205-218
    • Scanlan, C.N.1
  • 87
    • 63849131879 scopus 로고    scopus 로고
    • Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals
    • Scheid, J. F., et al. 2009. Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals. Nature 458:636-640.
    • (2009) Nature , vol.458 , pp. 636-640
    • Scheid, J.F.1
  • 88
    • 0036315133 scopus 로고    scopus 로고
    • Oligomeric and conformational properties of a proteolytically mature, disulfide-stabilized human immunodeficiency virus type 1 gp140 envelope glycoprotein
    • Schulke, N., et al. 2002. Oligomeric and conformational properties of a proteolytically mature, disulfide-stabilized human immunodeficiency virus type 1 gp140 envelope glycoprotein. J. Virol. 76:7760-7776.
    • (2002) J. Virol. , vol.76 , pp. 7760-7776
    • Schulke, N.1
  • 89
    • 73949127978 scopus 로고    scopus 로고
    • Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies
    • Seaman, M. S., et al. 2010. Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies. J. Virol. 84:1439-1452.
    • (2010) J. Virol. , vol.84 , pp. 1439-1452
    • Seaman, M.S.1
  • 90
    • 34548695901 scopus 로고    scopus 로고
    • Standardized assessment of NAb responses elicited in rhesus monkeys immunized with single- or multi-clade HIV-1 envelope immunogens
    • Seaman, M. S., et al. 2007. Standardized assessment of NAb responses elicited in rhesus monkeys immunized with single- or multi-clade HIV-1 envelope immunogens. Virology 367:175-186.
    • (2007) Virology , vol.367 , pp. 175-186
    • Seaman, M.S.1
  • 91
    • 0037317611 scopus 로고    scopus 로고
    • Alternative conformations of HIV-1 V3 loops mimic beta hairpins in chemokines, suggesting a mechanism for coreceptor selectivity
    • Sharon, M., et al. 2003. Alternative conformations of HIV-1 V3 loops mimic beta hairpins in chemokines, suggesting a mechanism for coreceptor selectivity. Structure 11:225-236.
    • (2003) Structure , vol.11 , pp. 225-236
    • Sharon, M.1
  • 92
    • 77950537428 scopus 로고    scopus 로고
    • Prolonged exposure of the HIV-1 gp41 membrane proximal region with L669S substitution
    • Shen, X., et al. 2010. Prolonged exposure of the HIV-1 gp41 membrane proximal region with L669S substitution. Proc. Natl. Acad. Sci. U. S. A. 107:5972-5977.
    • (2010) Proc. Natl. Acad. Sci. U. S. A. , vol.107 , pp. 5972-5977
    • Shen, X.1
  • 93
    • 64049092486 scopus 로고    scopus 로고
    • In vivo gp41 antibodies targeting the 2F5 monoclonal antibody epitope mediate human immunodeficiency virus type 1 neutralization breadth
    • Shen, X., et al. 2009. In vivo gp41 antibodies targeting the 2F5 monoclonal antibody epitope mediate human immunodeficiency virus type 1 neutralization breadth. J. Virol. 83:3617-3625.
    • (2009) J. Virol. , vol.83 , pp. 3617-3625
    • Shen, X.1
  • 94
    • 67650453747 scopus 로고    scopus 로고
    • Human immunodeficiency virus type 1 elite neutralizers: individuals with broad and potent neutralizing activity identified using a high-throughput neutralization assay together with an analytical selection algorithm
    • Simek, M. D., et al. 2009. Human immunodeficiency virus type 1 elite neutralizers: individuals with broad and potent neutralizing activity identified using a high-throughput neutralization assay together with an analytical selection algorithm. J. Virol. 83:7337-7348.
    • (2009) J. Virol. , vol.83 , pp. 7337-7348
    • Simek, M.D.1
  • 95
    • 0032169683 scopus 로고    scopus 로고
    • Effect of major deletions in the V1 and V2 loops of a macrophage-tropic HIV type 1 isolate on viral envelope structure, cell entry, and replication
    • Stamatatos, L., M. Wiskerchen, and C. Cheng-Mayer. 1998. Effect of major deletions in the V1 and V2 loops of a macrophage-tropic HIV type 1 isolate on viral envelope structure, cell entry, and replication. AIDS Res. Hum. Retroviruses 14:1129-1139.
    • (1998) AIDS Res. Hum. Retroviruses , vol.14 , pp. 1129-1139
    • Stamatatos, L.1    Wiskerchen, M.2    Cheng-Mayer, C.3
  • 97
    • 57349127300 scopus 로고    scopus 로고
    • Initial B-cell responses to transmitted human immunodeficiency virus type 1 virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia
    • Tomaras, G. D., et al. 2008. Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia. J. Virol. 82:12449-12463.
    • (2008) J. Virol. , vol.82 , pp. 12449-12463
    • Tomaras, G.D.1
  • 98
    • 9044241681 scopus 로고    scopus 로고
    • Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1
    • Trkola, A., et al. 1996. Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1. J. Virol. 70:1100-1108.
    • (1996) J. Virol. , vol.70 , pp. 1100-1108
    • Trkola, A.1
  • 99
    • 0345471066 scopus 로고    scopus 로고
    • Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120
    • Veazey, R. S., et al. 2003. Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120. Nat. Med. 9:343-346.
    • (2003) Nat. Med. , vol.9 , pp. 343-346
    • Veazey, R.S.1
  • 100
    • 77953543379 scopus 로고    scopus 로고
    • Rational antibody-based HIV-1 vaccine design: current approaches and future directions
    • Walker, L. M., and D. R. Burton. 2010. Rational antibody-based HIV-1 vaccine design: current approaches and future directions. Curr. Opin. Immunol. 22:358-366.
    • (2010) Curr. Opin. Immunol. , vol.22 , pp. 358-366
    • Walker, L.M.1    Burton, D.R.2
  • 102
    • 70349887757 scopus 로고    scopus 로고
    • Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target
    • Walker, L. M., et al. 2009. Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target. Science 326:285-289.
    • (2009) Science , vol.326 , pp. 285-289
    • Walker, L.M.1
  • 103
    • 77958115264 scopus 로고    scopus 로고
    • A limited number of antibody specificities mediate broad and potent serum neutralization in selected HIV-1 infected individuals
    • Walker, L. M., et al. 2010. A limited number of antibody specificities mediate broad and potent serum neutralization in selected HIV-1 infected individuals. PLoS Pathog. 6:e1001028.
    • (2010) PLoS Pathog , vol.6
    • Walker, L.M.1
  • 104
    • 0037456827 scopus 로고    scopus 로고
    • Antibody neutralization and escape by HIV-1
    • Wei, X., et al. 2003. Antibody neutralization and escape by HIV-1. Nature 422:307-312.
    • (2003) Nature , vol.422 , pp. 307-312
    • Wei, X.1
  • 105
    • 80052942203 scopus 로고    scopus 로고
    • Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing
    • Wu, X., et al. 2011. Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing. Science 333:1593-1602.
    • (2011) Science , vol.333 , pp. 1593-1602
    • Wu, X.1
  • 106
    • 77954920017 scopus 로고    scopus 로고
    • Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1
    • Wu, X., et al. 2010. Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1. Science 329:856-861.
    • (2010) Science , vol.329 , pp. 856-861
    • Wu, X.1
  • 107
    • 0036436313 scopus 로고    scopus 로고
    • Characterization of CD4-induced epitopes on the HIV type 1 gp120 envelope glycoprotein recognized by neutralizing human monoclonal antibodies
    • Xiang, S. H., N. Doka, R. K. Choudhary, J. Sodroski, and J. E. Robinson. 2002. Characterization of CD4-induced epitopes on the HIV type 1 gp120 envelope glycoprotein recognized by neutralizing human monoclonal antibodies. AIDS Res. Hum. Retroviruses 18:1207-1217.
    • (2002) AIDS Res. Hum. Retroviruses , vol.18 , pp. 1207-1217
    • Xiang, S.H.1    Doka, N.2    Choudhary, R.K.3    Sodroski, J.4    Robinson, J.E.5
  • 108
    • 33644752818 scopus 로고    scopus 로고
    • Simian immunodeficiency virus engrafted with human immunodeficiency virus type 1 (HIV-1)-specific epitopes: replication, neutralization, and survey of HIV-1-positive plasma
    • Yuste, E., et al. 2006. Simian immunodeficiency virus engrafted with human immunodeficiency virus type 1 (HIV-1)-specific epitopes: replication, neutralization, and survey of HIV-1-positive plasma. J. Virol. 80:3030-3041.
    • (2006) J. Virol. , vol.80 , pp. 3030-3041
    • Yuste, E.1
  • 109
    • 77954943648 scopus 로고    scopus 로고
    • Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01
    • Zhou, T., et al. 2010. Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01. Science 329:811-817.
    • (2010) Science , vol.329 , pp. 811-817
    • Zhou, T.1
  • 110
    • 0034759882 scopus 로고    scopus 로고
    • Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41
    • Zwick, M. B., et al. 2001. Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41. J. Virol. 75:10892-10905.
    • (2001) J. Virol. , vol.75 , pp. 10892-10905
    • Zwick, M.B.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.